Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Seer, Inc.
  6. News
  7. Summary
    SEER   US81578P1066

SEER, INC.

(SEER)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Seer : to Report Third Quarter Financial Results on November 9, 2021

10/12/2021 | 04:06pm EST

REDWOOD CITY, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report financial results for the third quarter 2021 after market close on Tuesday, November 9, 2021. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Live audio of the webcast will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the event.

About Seer
Seer is a life sciences company developing transformative products that open up a new gateway to the proteome. Seer is commercializing its Proteograph™ Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform deep, unbiased proteomic analysis at scale in a matter of hours. Seer designed the Proteograph workflow to be efficient and easy-to-use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution that can be adopted by nearly any lab. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visit www.seer.bio.

Investor Contact
Carrie Mendivil
investor@seer.bio

Media Contact
Karen Possemato
pr@seer.bio


All news about SEER, INC.
11/29SEER : Appoints Meeta Gulyani to its Board of Directors - Form 8-K
PU
11/29SEER, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits ..
AQ
11/29Seer Appoints Meeta Gulyani to its Board of Directors
AQ
11/29Seer, Inc. Appoints Meeta Gulyani to its Board of Directors
CI
11/22Seer to Participate in the Piper Sandler Virtual Healthcare Conference
AQ
11/17SEER ALERT : Bragar Eagel & Squire, P.C. is Investigating Seer, Inc. on Behalf of SEER Sto..
BU
11/09SEER ALERT : Bragar Eagel & Squire, P.C. is Investigating Seer, Inc. on Behalf of Seer Sto..
BU
11/09SEER, INC. Management's Discussion and Analysis of Financial Condition and Results of ..
AQ
11/09Seer Reports Third Quarter 2021 Financial Results - Form 8-K
PU
11/09Earnings Flash (SEER) SEER Reports Q3 Revenue $2.2M, vs. Street Est of $1.23M
MT
More news
Analyst Recommendations on SEER, INC.
More recommendations
Financials (USD)
Sales 2021 5,35 M - -
Net income 2021 -72,4 M - -
Net cash 2021 490 M - -
P/E ratio 2021 -21,2x
Yield 2021 -
Capitalization 1 553 M 1 553 M -
EV / Sales 2021 199x
EV / Sales 2022 78,2x
Nbr of Employees 60
Free-Float 72,9%
Chart SEER, INC.
Duration : Period :
Seer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SEER, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 25,17 $
Average target price 53,67 $
Spread / Average Target 113%
EPS Revisions
Managers and Directors
Omid C. Farokhzad Chairman & Chief Executive Officer
Omead Ostadan President, Chief Operating Officer & Director
David R. Horn Chief Financial Officer
David L. Hallal Lead Independent Director
Robert S. Langer Director
Sector and Competitors
1st jan.Capi. (M$)
SEER, INC.-55.17%1 369
METTLER-TOLEDO INTERNATIONAL INC.34.73%35 294
TECAN GROUP LTD.19.41%6 897
JEOL LTD.79.45%3 880
OLINK HOLDING AB (PUBL)0.00%2 221
NINGBO YONGXIN OPTICS CO., LTD.190.12%1 931